Literature DB >> 21457702

Nitric oxide reduces sickle hemoglobin polymerization: potential role of nitric oxide-induced charge alteration in depolymerization.

Tohru Ikuta1, Hemant S Thatte, Jay X Tang, Ishita Mukerji, Kelly Knee, Kenneth R Bridges, Sabina Wang, Pedro Montero-Huerta, Ratan Mani Joshi, C Alvin Head.   

Abstract

We previously demonstrated that inhaling nitric oxide (NO) increases the oxygen affinity of sickle red blood cells (RBCs) in patients with sickle cell disease (SCD). Our recent studies found that NO lowered the P(50) values of sickle hemoglobin (HbS) hemolysates but did not increase methemoglobin (metHb) levels, supporting the role of NO, but not metHb, in the oxygen affinity of HbS. Here we examine the mechanism by which NO increases HbS oxygen affinity. Because anti-sickling agents increase sickle RBC oxygen affinity, we first determined whether NO exhibits anti-sickling properties. The viscosity of HbS hemolysates, measured by falling ball assays, increased upon deoxygenation; NO treatment reduced the increment. Multiphoton microscopic analyses showed smaller HbS polymers in deoxygenated sickle RBCs and HbS hemolysates exposed to NO. These results suggest that NO inhibits HbS polymer formation and has anti-sickling properties. Furthermore, we found that HbS treated with NO exhibits an isoelectric point similar to that of HbA, suggesting that NO alters the electric charge of HbS. NO-HbS adducts had the same elution time as HbA upon high performance liquid chromatography analysis. This study demonstrates that NO may disrupt HbS polymers by abolishing the excess positive charge of HbS, resulting in increased oxygen affinity.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21457702      PMCID: PMC3889650          DOI: 10.1016/j.abb.2011.03.013

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  54 in total

1.  Arterialization of peripheral venous blood in sickle cell disease.

Authors:  Masoud Nahavandi; Richard M Millis; Fatemeh Tavakkoli; Meville Q Wyche; Elliott Perlin; William P Winter; Oswaldo Castro
Journal:  J Natl Med Assoc       Date:  2002-05       Impact factor: 1.798

2.  Sickle hemoglobin fibers: mechanisms of depolymerization.

Authors:  Gunjan Agarwal; Jiang Cheng Wang; Suzanna Kwong; Scott M Cohen; Frank A Ferrone; Robert Josephs; Robin W Briehl
Journal:  J Mol Biol       Date:  2002-09-13       Impact factor: 5.469

3.  Kinetics of sickle hemoglobin polymerization. I. Studies using temperature-jump and laser photolysis techniques.

Authors:  F A Ferrone; J Hofrichter; W A Eaton
Journal:  J Mol Biol       Date:  1985-06-25       Impact factor: 5.469

4.  Viscosity studies of deoxyhemoglobin S: evidence for formation of microaggregates during the lag phase.

Authors:  E H Danish; J W Harris
Journal:  J Lab Clin Med       Date:  1983-04

5.  Conformation and spin state in methemoglobin.

Authors:  P Hensley; S J Edelstein; D C Wharton; Q H Gibson
Journal:  J Biol Chem       Date:  1975-02-10       Impact factor: 5.157

6.  Nitric oxide binding to oxygenated hemoglobin under physiological conditions.

Authors:  Z Huang; J G Louderback; M Goyal; F Azizi; S B King; D B Kim-Shapiro
Journal:  Biochim Biophys Acta       Date:  2001-12-19

7.  Survival rates and properties of sickle cell anemia red cells treated with nitrogen mustard.

Authors:  E F Roth; B Wenz; H B Lee; M Fabry; H Chang; D K Kaul; S Baez; R L Nagel
Journal:  Prog Clin Biol Res       Date:  1987

8.  Delay time of hemoglobin S polymerization prevents most cells from sickling in vivo.

Authors:  A Mozzarelli; J Hofrichter; W A Eaton
Journal:  Science       Date:  1987-07-31       Impact factor: 47.728

9.  Reaction of nitric oxide with heme proteins and model compounds of hemoglobin.

Authors:  V S Sharma; T G Traylor; R Gardiner; H Mizukami
Journal:  Biochemistry       Date:  1987-06-30       Impact factor: 3.162

10.  A new high-performance liquid chromatographic procedure to quantitate hemoglobin A1c and other minor hemoglobins in blood of normal, diabetic, and alcoholic individuals.

Authors:  T H Huisman; J B Henson; J B Wilson
Journal:  J Lab Clin Med       Date:  1983-08
View more
  10 in total

Review 1.  cGMP modulation therapeutics for sickle cell disease.

Authors:  Nicola Conran; Lidiane Torres
Journal:  Exp Biol Med (Maywood)       Date:  2019-01-28

2.  GBT1118, a voxelotor analog, protects red blood cells from damage during severe hypoxia.

Authors:  Michael Tarasev; Marta Ferranti; Andrew Herppich; Patrick Hines
Journal:  Am J Transl Res       Date:  2022-01-15       Impact factor: 4.060

3.  Imaging flow cytometry for automated detection of hypoxia-induced erythrocyte shape change in sickle cell disease.

Authors:  Eduard J van Beers; Leigh Samsel; Laurel Mendelsohn; Rehan Saiyed; Kleber Y Fertrin; Christine A Brantner; Mathew P Daniels; James Nichols; J Philip McCoy; Gregory J Kato
Journal:  Am J Hematol       Date:  2014-04-12       Impact factor: 10.047

4.  Molecular mechanisms underlying synergistic adhesion of sickle red blood cells by hypoxia and low nitric oxide bioavailability.

Authors:  Diana R Gutsaeva; Pedro Montero-Huerta; James B Parkerson; Shobha D Yerigenahally; Tohru Ikuta; C Alvin Head
Journal:  Blood       Date:  2014-01-15       Impact factor: 22.113

5.  Visualizing red blood cell sickling and the effects of inhibition of sphingosine kinase 1 using soft X-ray tomography.

Authors:  Michele C Darrow; Yujin Zhang; Bertrand P Cinquin; Elizabeth A Smith; Rosanne Boudreau; Ryan H Rochat; Michael F Schmid; Yang Xia; Carolyn A Larabell; Wah Chiu
Journal:  J Cell Sci       Date:  2016-08-09       Impact factor: 5.285

Review 6.  Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management.

Authors:  Samir K Ballas; Muge R Kesen; Morton F Goldberg; Gerard A Lutty; Carlton Dampier; Ifeyinwa Osunkwo; Winfred C Wang; Carolyn Hoppe; Ward Hagar; Deepika S Darbari; Punam Malik
Journal:  ScientificWorldJournal       Date:  2012-08-01

Review 7.  A systematic review of known mechanisms of hydroxyurea-induced fetal hemoglobin for treatment of sickle cell disease.

Authors:  Gift D Pule; Shaheen Mowla; Nicolas Novitzky; Charles S Wiysonge; Ambroise Wonkam
Journal:  Expert Rev Hematol       Date:  2015-09-01       Impact factor: 2.819

8.  Nitric Oxide-cGMP Signaling Stimulates Erythropoiesis through Multiple Lineage-Specific Transcription Factors: Clinical Implications and a Novel Target for Erythropoiesis.

Authors:  Tohru Ikuta; Hassan Sellak; Nadine Odo; Adekunle D Adekile; Karin M L Gaensler
Journal:  PLoS One       Date:  2016-01-04       Impact factor: 3.240

9.  Lidocaine and Ketamine Infusions as Adjunctive Pain Management Therapy: A Retrospective Analysis of Clinical Outcomes in Hospitalized Patients Admitted for Pain Related to Sickle Cell Disease.

Authors:  Nicolas A Zavala; Randall W Knoebel; Magdalena Anitescu
Journal:  Front Pain Res (Lausanne)       Date:  2022-08-04

Review 10.  Sickle cell disease: progress towards combination drug therapy.

Authors:  Betty S Pace; Athena Starlard-Davenport; Abdullah Kutlar
Journal:  Br J Haematol       Date:  2021-01-20       Impact factor: 6.998

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.